ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 651851 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 651851; 2) Community: the network communities that were significantly associated with the response to NSC 651851; 3) Molecule: the relationships between components within communities and NSC 651851; 4) MDR: the compounds that were significantly associated with the NSC 651851.

NSC Compound Enrichment Correlation
NSC 699767 Null 0.00888636978630782 -0.0793802
NSC 734749 6-(3-Azido-propyl)-2,3-dimethoxthy-5,11-dioxo-5,11-dihydro-6 H-indeno[1,2-c]isoquinoline-9-carbonitrile 0.00888636978630782 0.058222832
NSC 268965 Benzaldehyde, 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]- 0.0102077332082016 0.51135072
NSC 658725 Null 0.0102077332082017 0.24910804
NSC 681636 Camptothecin Derivative 0.0102077332082017 0.49978076
NSC 681645 Camptothecin Derivative 0.0102077332082017 0.54323431
NSC 683558 Camptothecin Derivative 0.0102077332082017 0.51950178
NSC 716258 Null 0.0102077332082017 0.17416411
NSC 75520 Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) 0.0102077332082017 0.44790147
NSC 756078 1-[5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-3-yl]-5-phenyl-1H-tetrazole 0.0102077332082017 0.044719024
Total:52  Current:9    [First] [Prev] [Next] [Last]